Your browser doesn't support javascript.
loading
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.
Thompson, Ravyn M; Dytfeld, Dominik; Reyes, Leticia; Robinson, Reeder M; Smith, Brittany; Manevich, Yefim; Jakubowiak, Andrzej; Komarnicki, Mieczyslaw; Przybylowicz-Chalecka, Anna; Szczepaniak, Tomasz; Mitra, Amit K; Van Ness, Brian G; Luczak, Magdalena; Dolloff, Nathan G.
Afiliación
  • Thompson RM; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
  • Dytfeld D; Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
  • Reyes L; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
  • Robinson RM; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
  • Smith B; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
  • Manevich Y; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
  • Jakubowiak A; University of Chicago, Chicago, IL, USA.
  • Komarnicki M; Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
  • Przybylowicz-Chalecka A; Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
  • Szczepaniak T; Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
  • Mitra AK; University of Minnesota, Minneapolis, MN, USA.
  • Van Ness BG; University of Minnesota, Minneapolis, MN, USA.
  • Luczak M; Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
  • Dolloff NG; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
Oncotarget ; 8(22): 35863-35876, 2017 May 30.
Article en En | MEDLINE | ID: mdl-28415782
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Tiadiazoles / Resistencia a Antineoplásicos / Bencenoacetamidas / Inhibidores de Proteasoma / Glutaminasa / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Tiadiazoles / Resistencia a Antineoplásicos / Bencenoacetamidas / Inhibidores de Proteasoma / Glutaminasa / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos